Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

GSK-3: tricks of the trade for a multi-tasking kinase.

Doble BW, Woodgett JR.

J Cell Sci. 2003 Apr 1;116(Pt 7):1175-86. Review.

2.

The interaction of glycogen synthase kinase-3 (GSK-3) with the cell cycle.

Ryves WJ, Harwood AJ.

Prog Cell Cycle Res. 2003;5:489-95. Review.

PMID:
14593744
3.
5.

Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.

Fishman P, Madi L, Bar-Yehuda S, Barer F, Del Valle L, Khalili K.

Oncogene. 2002 Jun 6;21(25):4060-4.

6.

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.

Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ, Rausch OL, Murphy GJ, Carter PS, Roxbee Cox L, Mills D, Brown MJ, Haigh D, Ward RW, Smith DG, Murray KJ, Reith AD, Holder JC.

Chem Biol. 2000 Oct;7(10):793-803.

8.

Phosphorylation by glycogen synthase kinase-3 beta down-regulates Notch activity, a link for Notch and Wnt pathways.

Espinosa L, Inglés-Esteve J, Aguilera C, Bigas A.

J Biol Chem. 2003 Aug 22;278(34):32227-35.

9.
10.

Glycogen synthase kinase 3: a key regulator of cellular fate.

Forde JE, Dale TC.

Cell Mol Life Sci. 2007 Aug;64(15):1930-44. Review.

PMID:
17530463
11.

Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification.

Farr GH 3rd, Ferkey DM, Yost C, Pierce SB, Weaver C, Kimelman D.

J Cell Biol. 2000 Feb 21;148(4):691-702.

12.

The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation.

Bax B, Carter PS, Lewis C, Guy AR, Bridges A, Tanner R, Pettman G, Mannix C, Culbert AA, Brown MJ, Smith DG, Reith AD.

Structure. 2001 Dec;9(12):1143-52.

13.

[A new target for diabetes therapy: advances in the research of glycogen synthase kinase-3 inhibitors].

Liu SN, Shen ZF.

Yao Xue Xue Bao. 2007 Dec;42(12):1227-31. Review. Chinese.

PMID:
18338632
14.

Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways.

Manoukian AS, Woodgett JR.

Adv Cancer Res. 2002;84:203-29. Review.

PMID:
11883528
15.

Wnt signaling controls the phosphorylation status of beta-catenin.

van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H.

J Biol Chem. 2002 May 17;277(20):17901-5.

16.

Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism.

Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X.

Cell. 2002 Mar 22;108(6):837-47.

17.

Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesis.

Fischer L, Boland G, Tuan RS.

J Cell Biochem. 2002;84(4):816-31.

PMID:
11835406
19.
20.

A role for glycogen synthase kinase-3 in mitotic spindle dynamics and chromosome alignment.

Wakefield JG, Stephens DJ, Tavaré JM.

J Cell Sci. 2003 Feb 15;116(Pt 4):637-46.

Items per page

Supplemental Content

Support Center